Details

Study of the in vitro antagonistic activity of various single-strain and multi-strain probiotics against Escherichia coli
ID Fijan, Sabina (Author), ID Šulc, Dunja (Author), ID Steyer, Andrej (Author)

.pdfPDF - Presentation file, Download (352,49 KB)
MD5: AD484B190062915C0CBEA4EAFE31D93A
URLURL - Source URL, Visit http://www.mdpi.com/1660-4601/15/7/1539 This link opens in a new window

Abstract
Escherichia coli is an important commensal of our gut, however, many pathogenic strains exist, causing various severe infections in the gut or beyond. Due to several antibiotic resistance patterns of E. coli, research of alternative treatments or adjuvant therapy is important. One of these is the use of probiotics as antagonistic agents against E. coli. Most published studies investigate only one strain of E. coli and single-strain probiotics. The objectives of this study were to evaluate the antagonistic activity of selected single-strain and multi-strain probiotic supplements against selected clinical E. coli pathotypes using the in vitro agar spot test and the co-culturing method. Molecular methods were used to determine the presence of the genus lactobacilli and bifidobacteria as well as certain selected strains in the probiotic supplements. The agar-spot test showed that the multi-strain probiotics were more effective than the single-strain probiotics. On the other hand, the co-culturing method showed the opposite result, indicating that results are importantly influenced by the chosen method. The most effective single-strain probiotics against E. coli strains were Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus reuteri DSM 17938. The most effective multi-strain probiotics contained lactobacilli, bifidobacteria and enterococci strains, thus proving that most effective probiotics against E. coli strains are the lactic acid bacteria and bifidobacteria. The overall results from both in vitro tests reveal that all selected probiotics exhibited an antagonistic activity against all E. coli strains. From a public health perspective probiotics have thus proved to be successful in inhibiting the growth of E. coli and could therefore be used as adjuvant therapy or alternative therapy in E. coli infections.

Language:English
Keywords:probiotic, Escherichia coli, antagonistic effect
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2018
Number of pages:15 str.
Numbering:Vol. 15, iss. 7, art. 1539
PID:20.500.12556/RUL-175392 This link opens in a new window
UDC:579
ISSN on article:1660-4601
DOI:10.3390/ijerph15071539 This link opens in a new window
COBISS.SI-ID:33872089 This link opens in a new window
Publication date in RUL:14.11.2025
Views:80
Downloads:9
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:International journal of environmental research and public health
Shortened title:Int. j. environ. res. public health
Publisher:MDPI
ISSN:1660-4601
COBISS.SI-ID:1818965 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:probiotik, Escherichia coli, antagonističen učinek

Projects

Funder:Public Scholarship, Development, Disability and Maintenance Fund of the Republic of Slovenia
Acronym:SezMiPro

Funder:ARRS - Slovenian Research Agency
Project number:P3-0083
Name:Odnosi parazitskega obstajanja

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back